Interview with Kim Jensen - stem cells in the skin and intestine

Kim Jensen is Associate Professor at the Biotech Research & Innovation Centre (BRIC), Universty of Copenhagen, Denmark. Here, he talks about his scientific career past, present and future in the field of epithelial stem cell research.

Interview with Austin Smith on The Node

We always enjoy meeting the scientists behind the science, and hearing their stories of research. Last month we profiled interviews with Juergen Knoblich and Hans Clevers. This month Catarina Vicente, of Development and The Node, has published an interview with another EuroStemCell partner and originator, Austin Smith.

Interview with Graziella Pellegrini – Using stem cells to cure blindness

Professor Graziella Pellegrini is one of the principal scientists on the ground breaking, corneal repair system Holoclar ®.  Working throughout Italy over the past 27 years she is now based at the Centre for Regenerative Medicine “Stefano Ferrari” at the University of Modena and Reggio Emilia. 

Interview with Michele De Luca – Epithelial cells and regrowing corneal epithelium

Michele de Luca began his stem cell research career working in Boston in the 80s, after training as an endocrinologist.  Alongside Professor Howard Green he worked with epithelial stem cells for the treatment of patients with burns to the skin, before moving back to Italy.  He is director of the Centre for Regenerative Medicine "Stefano Ferrari" at the University of Modena and Reggio Emilia.

Interview with Henrik Semb: the pancreas, beta cells and diabetes

Professor Henrik Semb is the director of the Danish stem cell center. His research group focuses on how organs are formed and cells acquire their fates in vivo. In particular, they are interested in how processes such as cell shape changes, movement and polarity, not only affect 3D architecture of the developing organ but also what type of cells are made.  In vivo findings from their lab have given insight into coaxing human pluripotent stem cells into functional insulin-producing beta cells as a source for therapy in type 1 diabetes.

Interview with Malin Parmar: cell therapy for Parkinson’s disease

Malin Parmar heads a research group focused on developmental and regenerative neurobiology at Lund University in Sweden. The ultimate goal of her research is to develop cell therapy for Parkinson’s disease.

At this year’s Hydra summer school I spoke to Malin about how she got started in stem cell research, what she’s working on at the moment, and her view of the prospects for treating Parkinson’s disease with stem cells.

Interview with Michaela Frye: RNA modifications, an upcoming field

Dr Michaela Frye began her research career in molecular ecology and evolution , working with snails, before a shift to cystic fibrosis for her PhD research. After her PhD she worked as a post-doc with Fiona Watt at a Cancer Research UK (CRUK) research institute in London. In 2007 she was awarded a CRUK career development fellowship to set up a group at the Wellcome Trust - MRC Stem Cell Institute, Cambridge, where she is now a senior research fellow. We spoke to Michaela at the Hydra Stem Cell Sumer School earlier this year, where she gave a lecture on epigenetic regulation of differentiation and development.

Stem cells in the commercial world: An interview with Stephen Elliman

A lot of stem cell research happens in universities and other academic centres, but companies will play an increasing role as research progresses towards new medical applications. To get a flavour of how small companies are getting involved with cell therapy research and the challenges they face, meet Stephen Elliman, Head of Research and Development at Orbsen Therapeutics. Our partners have spoken to Steve and you can read and watch on film some of the things he told us.

Interview with Connie Eaves: blood stem cells in development and disease

Dr. Connie Eaves was a co-founder of the Terry Fox Laboratory in 1981, and has served both as its Deputy Director and Director. During her PhD studies in the late 1960’s, she discovered that two groups of cells contribute to the generation of antibody responses, heralding the subsequent recognition of two important types of immune cells: B and T cells.She has since contributed many seminal advances to our understanding of stem cells involved in blood formation and how they work in both health and disease.

Meet scientist and artist Ariel Ruiz i Altaba

Prof Ariel Ruiz i Altaba is Coordinator of the EU-funded research project HEALING, was founding director of the Swiss Stem Cell Network and is professor at the Department of Genetic Medicine and Development, Université de Genève, Switzerland. He is also an established visual artist. Emma Kemp met Ariel to hear more about science, art and how they might come together to build an understanding of the evolving world around us.

Syndicate content